SANGAMO THERAPEUTICS, INC Contracts & Agreements

136 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended and Restated Collaboration and License Agreement between the Company and Kite Pharma, Inc., dated as of September 11, 2019
Collaboration Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
2019
License Agreement between the Company and Genentech, Inc., dated August 2, 202
License Agreements
SANGAMO THERAPEUTICS, INC
2024
Form of Pre-Funded Warrant to Purchase Common Stock
Warrant Agreements
SANGAMO THERAPEUTICS, INC
2024
Form of Warrant to Purchase Common Stock
Warrant Agreements
SANGAMO THERAPEUTICS, INC
2024
Form of Securities Purchase Agreement, dated March 21, 2024 by and among Sangamo Therapeutics, Inc. and the purchasers party thereto
Purchase Agreements
SANGAMO THERAPEUTICS, INC
2024
Placement Agent Agreement, dated March 21, 2024 by and among Sangamo Therapeutics, Inc. and Barclays Capital Inc. and Cantor Fitzgerald & Co
SANGAMO THERAPEUTICS, INC
2024
Description of Capital Stock
Stock Agreements
SANGAMO THERAPEUTICS, INC
2024
Amended and Restated 2018 Equity Incentive Plan of Sangamo Therapeutics, Inc
Bonus & Incentive Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
CA
2022
Letter Agreement between the Company and David Mark McClung dated November 1, 2021
SANGAMO THERAPEUTICS, INC
2022
Amended and Restated Office and Laboratory Lease between the Company and Point Richmond R&D Associates II, LLC, dated October 18, 2021
Lease Agreements
SANGAMO THERAPEUTICS, INC
2022
Letter Agreement between the Company and
SANGAMO THERAPEUTICS, INC
2021
Letter Agreement between the Company and
SANGAMO THERAPEUTICS, INC
Biotechnology
CA
2021
Ninth Amendment to Triple Net Laboratory Lease
Lease Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
2021
Letter Agreement between the Company and
SANGAMO THERAPEUTICS, INC
2021
Letter Agreement between the Company and
SANGAMO THERAPEUTICS, INC
2021
Description of
SANGAMO THERAPEUTICS, INC
Biotechnology
2021
Letter Agreement dated as of January 22, 2021 between Sangamo Therapeutics, Inc. and Sung Lee
SANGAMO THERAPEUTICS, INC
Biotechnology
CA
2021
Amendment No. 2 to Research Collaboration and License Agreement between the Company and Pfizer Inc., dated July 21, 2020
Collaboration Agreements
SANGAMO THERAPEUTICS, INC
2020
Collaboration and License
Collaboration Agreements
SANGAMO THERAPEUTICS, INC
2020
Open Market Sale Agreement, dated August 5, 2020, between Sangamo Therapeutics, Inc. and Jefferies LLC
SANGAMO THERAPEUTICS, INC
2020
Employment Agreement between the Company and Mark McClung effective as of April 13, 2020
Employment Agreements
SANGAMO THERAPEUTICS, INC
2020
Letter Agreement
SANGAMO THERAPEUTICS, INC
2020
Seventh Amendment to the Triple Net Laboratory Lease Agreement, dated May 2
Lease Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
2020
Eighth Amendment to the Triple Net Laboratory Lease Agreement, dated May 29, 2020, between the Registrant and Point Richmond R&D Associates II, LLC
Lease Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
2020
Amended and Restated 2018 Equity Incentive Plan of Sangamo Therapeutics, Inc
Bonus & Incentive Agreements
SANGAMO THERAPEUTICS, INC
2020
Collaboration and License Agreement among the Company, Biogen MA, Inc. and Biogen International GmbH, dated February 26, 2020
Collaboration Agreements
SANGAMO THERAPEUTICS, INC
2020
Stock Purchase Agreement between the Company and Biogen MA, Inc., dated February 26, 2020
Stock Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
DE
2020
Form of Indemnity Agreement
SANGAMO THERAPEUTICS, INC
2020
Description of Securities of the Company
SANGAMO THERAPEUTICS, INC
2020
Employment Agreement between the Company and Sung Lee effective as of October 31, 2019
Employment Agreements
SANGAMO THERAPEUTICS, INC
2020
Employment Agreement between the Company and Gary Loeb effective as of June 6, 2019
Employment Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
CA
2020
Employment Agreement between the Company and Rolf Andrew (Andy) Ramelmeier effective as of November 1, 2017
Employment Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
CA
2020
Letter Amendment, dated December 17, 2019, to the Collaboration and License Agreement between the Company and Pfizer Inc., dated May 10, 2017
Collaboration Agreements
SANGAMO THERAPEUTICS, INC
2020
Amendment No. 1 to Research Collaboration and License Agreement between the Company and Pfizer., dated December 27, 2017, dated as of March 21, 2019
Collaboration Agreements
SANGAMO THERAPEUTICS, INC
2019
Underwriting Agreement, dated April 4, 2019, by and between Sangamo Therapeutics, Inc. and Cowen and Company, LLC, Wells Fargo Securities, LLC and Barclays Capital Inc., as...
Underwriting Agreements
SANGAMO THERAPEUTICS, INC
2019
2018 Equity Incentive Plan French Stock-Options Sub-Plan (the French Options Sub-Plan)
Bonus & Incentive Agreements
SANGAMO THERAPEUTICS, INC
2019
2018 Equity Incentive Plan French Restricted Stock Unit Award Sub-Plan (the French RSU Sub-Plan)
Bonus & Incentive Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
2019
Form of Stock Option Grant Notice (French employees) under the 2018 Plan and the French Options Sub-Plan
Stock Agreements
SANGAMO THERAPEUTICS, INC
2019
Form of Stock Option Agreement (French Employees) under the 2018 Plan and the French Options Sub-Plan
Stock Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
2019
Form of Restricted Stock Unit Grant Notice and Form of Restricted Stock Unit Award Agreement (French employees) under the 2018 Plan and the French RSU Sub-Plan
Stock Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
2019
Amended and Restated Severance Plan
Severance Agreements
SANGAMO THERAPEUTICS, INC
2019
Employment Agreement between the Company and Heather D. Turner, effective February 12, 2018
Employment Agreements
SANGAMO THERAPEUTICS, INC
2019
Employment Agreement between the Company and Stphane Boissel, effective October 1, 2018
Employment Agreements
SANGAMO THERAPEUTICS, INC
2019
Employment Agreement between the Company and Adrian Woolfson, effective January 21 2019
Employment Agreements
SANGAMO THERAPEUTICS, INC
2019
Fourth Amendment to Triple Net Laboratory Lease between the Company and Point Richmond R&D Associates II, LLC, dated June 10, 2016
Lease Agreements
SANGAMO THERAPEUTICS, INC
2019
Fifth Amendment to Triple Net Laboratory Lease between the Company and Point Richmond R&D Associates II, LLC, dated July 10, 2017
Lease Agreements
SANGAMO THERAPEUTICS, INC
2019
First Amendment to Lease Agreement between the Company and Marina Boulevard Property, LLC dated January 1, 2019
Lease Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
2019
Amendment Agreement to the Share Purchase Agreement dated October 1, 2018, among the Company and the Sellers
Share Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
2018
Amendment No. 1 to the Tender Offer Agreement dated October 1, 2018, between the Company and TxCell
SANGAMO THERAPEUTICS, INC
2018
Sixth Amendment to the Triple Net Laboratory Lease Agreement, dated May 23, 2018, between the Registrant and Point Richmond R&D Associates II, LLC
Lease Agreements
SANGAMO THERAPEUTICS, INC
2018
Share Purchase Agreement dated July 20, 2018, among the Company and the Sellers
Share Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
2018
Tender Offer Agreement dated July 20, 2018, between the Company and TxCell
SANGAMO THERAPEUTICS, INC
2018
Collaboration and License Agreement between the Company and Kite Pharma, Inc., dated February 20, 2018
Collaboration Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
2018
Amended and Restated Incentive Compensation Plan
Bonus & Incentive Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
2018
Underwriting Agreement, dated April 25, 2018, by and between Sangamo Therapeutics, Inc. and Merrill Lynch Pierce, Fenner & Smith Incorporated, J.P. Morgan Securities LLC and Cowen...
Underwriting Agreements
SANGAMO THERAPEUTICS, INC
2018
Form of Restricted Stock Unit Award Agreement under the 2013 Plan
Stock Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
CA
2018
Offer Letter between the Company and Curt A. Herberts, dated August 16, 2010
SANGAMO THERAPEUTICS, INC
Biotechnology
2018
Separation Agreement between the Company and Dale Ando, dated February 21, 2017
Separation Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
CA
2018
Lease Agreement between the Company and Marina Boulevard Property, LLC dated November 3, 2017
Lease Agreements
SANGAMO THERAPEUTICS, INC
2018
Research Collaboration and License Agreement between the Company and Pfizer Inc., dated December 28, 2017
Collaboration Agreements
SANGAMO THERAPEUTICS, INC
2018
Collaboration and License Agreement between Sangamo Therapeutics, Inc. and Pfizer, Inc., dated May 10, 2017
Collaboration Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
DE
2017
10,000,000 Shares SANGAMO THERAPEUTICS, INC. Common Stock, $0.01 par value UNDERWRITING AGREEMENT
Underwriting Agreements
SANGAMO THERAPEUTICS, INC
2017
SANGAMO THERAPEUTICS, INC. AMENDED AND RESTATED AT-THE-MARKET OFFERING PROGRAM SALES AGREEMENT
Sales Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
NY
2017
EMPLOYMENT AGREEMENT
Employment Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
CA
2017
AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
2017
EMPLOYMENT AGREEMENT
Employment Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
CA
2017
SANGAMO THERAPEUTICS, INC. EXECUTIVE SEVERANCE PLAN INTRODUCTION
Severance Agreements
SANGAMO THERAPEUTICS, INC
2017
Signature(s) Guaranteed:Medallion Guarantee Stamp
Guarantee Agreements
SANGAMO THERAPEUTICS, INC
2017
SANGAMO BIOSCIENCES, INC. AT-THE-MARKET OFFERING PROGRAM SALES AGREEMENT
Sales Agreements
SANGAMO THERAPEUTICS, INC
2016
EIGHTH AMENDMENT TO THE RESEARCH AND COMMERCIAL LICENSE OPTION AGREEMENT
License Agreements
SANGAMO THERAPEUTICS, INC
2016
First Amendment to the License Agreement
License Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
2016
EMPLOYMENT AGREEMENT
Employment Agreements
SANGAMO THERAPEUTICS, INC
2016
Exhibit A
SANGAMO THERAPEUTICS, INC
Biotechnology
2016
Exhibit A 2016 BT Development Plan [***]
Development Agreements
SANGAMO THERAPEUTICS, INC
2016
AMENDED AND RESTATED COLLABORATION AND LICENSE AGREEMENT Between SANGAMO BIOSCIENCES, INC. And SHIRE INTERNATIONAL GMBH *** CONFIDENTIAL PORTIONS OMITTED AND FILED SEPARATELY WITH...
Collaboration Agreements
SANGAMO THERAPEUTICS, INC
2015
sEVENTH AMENDMENT TO THE LICENSE AGREEMENT
License Agreements
SANGAMO THERAPEUTICS, INC
2015
INDEMNIFICATION AGREEMENT
Indemnification Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
DE
2015
SANGAMO BIOSCIENCES, INC. AMENDED AND RESTATED 2013 STOCK INCENTIVE PLAN article One GENERAL PROVISIONS
Bonus & Incentive Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
2015
RESEARCH, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT by and between Sangamo BioSciences, Inc. and Juvenile Diabetes Research Foundation International Table of Contents
Development Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
NY
2015
GLOBAL RESEARCH, DEVELOPMENT AND COMMERCIALIZATION COLLABORATION AND LICENSE AGREEMENT
Collaboration Agreements
SANGAMO THERAPEUTICS, INC
2014
Amendment of 2013 Stock Incentive Plan on Reduction of Share Reserve
Bonus & Incentive Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
2014
NINTH AMENDMENT
SANGAMO THERAPEUTICS, INC
Biotechnology
2014
SANGAMO BIOSCIENCES, INC. 4,444,444 Shares of Common Stock par value $0.01 UnderwritingAgreement
Stock Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
NY
2014
SECOND AMENDMENT TO LEASE
Lease Agreements
SANGAMO THERAPEUTICS, INC
2013
THIRD AMENDMENT TO LEASE
Lease Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
2013
AGREEMENTAND PLAN OF MERGER by and among SANGAMO BIOSCIENCES, INC. CGACQUISITION SUB, INC. and CEREGENE, INC. and HAMILTON BIOVENTURESERVICES, INC., as Stockholders Representative...
Merger Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
DE
2013
6,100,000 Shares of Common Stock par value $0.001 915,000 Over-Allotment Shares Sangamo BioSciences, Inc. UNDERWRITING AGREEMENT
Underwriting Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
NY
2013
SANGAMO BIOSCIENCES, INC. RESTRICTED STOCK UNIT ISSUANCE AGREEMENT
Stock Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
CA
2013
SANGAMO BIOSCIENCES, INC. NOTICE OF GRANT OF STOCK OPTION
Stock Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
2013
SANGAMO BIOSCIENCES, INC. STOCK OPTION AGREEMENT
Stock Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
CA
2013
SANGAMO BIOSCIENCES, INC. NOTICE OF GRANT OF NON-EMPLOYEE DIRECTOR AUTOMATIC STOCK OPTION
Stock Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
2013
SANGAMO BIOSCIENCES, INC. NOTICE OF GRANT OF NON-EMPLOYEE DIRECTOR AUTOMATIC STOCK OPTION
Stock Agreements
SANGAMO THERAPEUTICS, INC
2013
SANGAMO BIOSCIENCES, INC. AUTOMATIC STOCK OPTION AGREEMENT
Stock Agreements
SANGAMO THERAPEUTICS, INC
2013
FIFTH AMENDMENT TO THE LICENSE AGREEMENT
License Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
2013
FOURTH AMENDMENT TO THE LICENSE AGREEMENT
License Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
2012
SANGAMO BIOSCIENCES, INC. INCENTIVE COMPENSATION PLAN ARTICLE I NAME AND PURPOSE
Bonus & Incentive Agreements
SANGAMO THERAPEUTICS, INC
2012
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
CA
2012
COLLABORATION AND LICENSE AGREEMENT
Collaboration Agreements
SANGAMO THERAPEUTICS, INC
2012
*** CONFIDENTIAL PORTIONS OMITTED AND FILED SEPARATELY WITH THE COMMISSION
SANGAMO THERAPEUTICS, INC
Biotechnology
2011
*** CONFIDENTIAL PORTIONS OMITTED AND FILED SEPARATELY WITH THE COMMISSION
SANGAMO THERAPEUTICS, INC
Biotechnology
2011
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreements
SANGAMO THERAPEUTICS, INC
2011
EMPLOYMENT AGREEMENT
Employment Agreements
SANGAMO THERAPEUTICS, INC
2011
6,700,000 Shares Sangamo BioSciences, Inc. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
SANGAMO THERAPEUTICS, INC
2011
SEVENTH AMENDMENT OF THE RESEARCH AND COMMERCIAL LICENSE OPTION AGREEMENT
License Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
2011
FIRST AMENDMENT OF THE LICENSE AGREEMENT
License Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
2009
SECOND AMENDMENT OF THE LICENSE AGREEMENT
License Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
2009
THIRD AMENDMENT TO THE LICENSE AGREEMENT
License Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
2009
3,000,000 Shares Sangamo Biosciences, Inc. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
NY
2009
COMMON STOCK PURCHASE AGREEMENT
Stock Agreements
SANGAMO THERAPEUTICS, INC
2009
LICENSE AGREEMENT
License Agreements
SANGAMO THERAPEUTICS, INC
2009
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreements
SANGAMO THERAPEUTICS, INC
2009
FIRST AMENDMENT TO EMPLOYMENT AGREEMENT
Employment Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
2009
RESEARCH AND LICENSE AGREEMENT
License Agreements
SANGAMO THERAPEUTICS, INC
2008
*** CONFIDENTIAL PORTIONS OMITTED AND FILED SEPARATELY WITH THE COMMISSION 2.
SANGAMO THERAPEUTICS, INC
Biotechnology
2008
LICENSE AGREEMENT
License Agreements
SANGAMO THERAPEUTICS, INC
2008
AMENDMENT TO 2004 STOCK INCENTIVE PLAN
Bonus & Incentive Agreements
SANGAMO THERAPEUTICS, INC
2008
SECOND RESEARCH AND LICENSE AGREEMENT BETWEEN GENENTECH, INC.
License Agreements
SANGAMO THERAPEUTICS, INC
2008
*** CONFIDENTIAL PORTIONS OMITTED AND FILED SEPARATELY WITH THE COMMISSION
SANGAMO THERAPEUTICS, INC
2008
SANGAMO BIOSCIENCES, INC.
SANGAMO THERAPEUTICS, INC
2007
our strategy
SANGAMO THERAPEUTICS, INC
2007
Current assets
SANGAMO THERAPEUTICS, INC
2007
Placement Agency Agreement dated July 16, 2007 between Sangamo BioSciences, Inc. and JMP Securities, Piper Jaffray & Co., Leerink Swann & Company and Janney Montgomery Scott LLC
Agency Agreements
SANGAMO THERAPEUTICS, INC
2007
COMMON STOCK PURCHASE AGREEMENT
Stock Agreements
SANGAMO THERAPEUTICS, INC
2007
SANGAMO BIOSCIENCES, INC. 3,000,000 SHARES
SANGAMO THERAPEUTICS, INC
2007
our strategy
SANGAMO THERAPEUTICS, INC
2007
Asset Purchase Agreement
Purchase Agreements
SANGAMO THERAPEUTICS, INC
Biotechnology
DE
2006
3,100,000 Shares SANGAMO BIOSCIENCES, INC. Common Stock PURCHASE AGREEMENT
Stock Agreements
SANGAMO THERAPEUTICS, INC
2006
our strategy
SANGAMO THERAPEUTICS, INC
2006
/s/ Dr. Casey Case Dr. Casey Case November 18, 2005 Date
SANGAMO THERAPEUTICS, INC
2005
TERMINATION OF SUBSCRIPTION AGREEMENT
Termination Agreements
SANGAMO THERAPEUTICS, INC
2005
5,080,000 Shares SANGAMO BIOSCIENCES, INC. Common Stock PLACEMENT AGENCY AGREEMENT
Stock Agreements
SANGAMO THERAPEUTICS, INC
2005
SUBSCRIPTION AGREEMENT
Subscription Agreements
SANGAMO THERAPEUTICS, INC
2005
our strategy
SANGAMO THERAPEUTICS, INC
2005
THIRDAMENDMENT TO LICENSEAGREEMENT
SANGAMO THERAPEUTICS, INC
2004
SECOND AMENDMENT TO LICENSE AGREEMENT
License Agreements
SANGAMO THERAPEUTICS, INC
2003
FIRST AMENDMENT TO RESEARCH FUNDING AGREEMENT
Funding Agreements
SANGAMO THERAPEUTICS, INC
2003